- Macular oedema (retinal vein occlusion) - ranibizumab
- Ovarian, fallopian tube and primary peritoneal cancer (recurrent advanced, platinum-sensitive or partially platinum-sensitive) - bevacizumab
- Social anxiety disorder
- Schizophrenia or bipolar disorder - loxapine inhalation (terminated appraisal)
- Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer
Blog del Servicio de Información Biomédica y Apoyo a la Investigación (SiBi). Hospital Universitario Miguel Servet (Zaragoza)
6.6.13
Guías NICE mayo 2013
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario